Molecule Holdings Stock Net Income
| EVRRFDelisted Stock | USD 0 0.00 0.00% |
Molecule Holdings technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Molecule Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Molecule Holdings' valuation are provided below:Molecule Holdings does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Molecule |
Search Suggestions
| E | Eni SpA ADR | Company |
| EFSCP | Enterprise Financial Services | Company |
| EAD | Allspring Income Opportunities | Fund |
| EU | enCore Energy Corp | ETF |
| EMCLOUD | BVP Nasdaq Emerging | Index |
| EM | EM | Cryptocurrency |
| E0R75RAB2 | AICNRA 575 15 JUN 33 | Corporate Bond |
| ESUSD | E Mini SP 500 | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Molecule Holdings reported net income of (4.23 Million). This is 101.24% lower than that of the Metals & Mining sector and significantly lower than that of the Materials industry. The net income for all United States stocks is 100.74% higher than that of the company.
Molecule Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molecule Holdings' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Molecule Holdings could also be used in its relative valuation, which is a method of valuing Molecule Holdings by comparing valuation metrics of similar companies.Molecule Holdings is currently under evaluation in net income category among its peers.
Molecule Fundamentals
| Return On Equity | -10.88 | |||
| Return On Asset | -0.41 | |||
| Profit Margin | (2.43) % | |||
| Operating Margin | (2.15) % | |||
| Current Valuation | 5.39 M | |||
| Shares Outstanding | 97.78 M | |||
| Shares Owned By Insiders | 16.52 % | |||
| Price To Earning | (2.27) X | |||
| Price To Book | 12.35 X | |||
| Price To Sales | 0.0001 X | |||
| Revenue | 455.26 K | |||
| Gross Profit | (499.74 K) | |||
| EBITDA | (3 M) | |||
| Net Income | (4.23 M) | |||
| Cash And Equivalents | 73.25 K | |||
| Total Debt | 817.09 K | |||
| Debt To Equity | 1.37 % | |||
| Current Ratio | 0.31 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (2.87 M) | |||
| Earnings Per Share | (0.04) X | |||
| Number Of Employees | 15 | |||
| Beta | -0.64 | |||
| Market Capitalization | 1.45 M | |||
| Total Asset | 5.96 M | |||
| Retained Earnings | (26.52 M) | |||
| Working Capital | 504 K | |||
| Current Asset | 1.13 M | |||
| Current Liabilities | 622 K | |||
| Z Score | -5.0 | |||
| Net Asset | 5.96 M |
About Molecule Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molecule Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecule Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecule Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Molecule Pink Sheet
If you are still planning to invest in Molecule Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molecule Holdings' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |